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Abstract
Background
Zoonotic visceral leishmaniasis (ZVL) caused by Leishmania infantum is endemic with an
epidemiological profile of a paediatric disease in Tunisia. In the context of a high fatality rate,
identifying risk factors for in-hospital mortality in children treated for ZVL is of major epidemi-
ological importance.
Design
A retrospective (case-control) study included 230 immuno-competent children diagnosed
and confirmed with primary ZVL in the paediatric department of the University Hospital of
Kairouan between 2004 and 2014. Forty-seven per cent (47%) were children under 18
months of age, and with a male / female ratio of 1.01:1.
Results
The overall case-fatality was 6% (n = 14). The risk factors for in-hospital death identified by
a multivariate analysis were: bleeding at admission (OR = 25.5, 95% CI: 2.26–287.4; p =
0.009), white cell count less than 4000/mm3 (OR = 5.66, 95% CI: 1.16–27.6; p = 0.032),
cytolysis (OR = 28.13, 95% CI: 4.55–173.6; p < 0.001), and delay between onset of symp-
toms and admission 15 days (OR = 11, 95% CI: 1.68–72; p = 0.012).
Conclusion
The results strongly suggest that paediatric patients admitted 15 days after onset of symp-
toms, with bleeding, white cell counts below 4,000/mm3, and cytolysis at admission should
be considered severe cases and subsequently, they are at high risk of mortality. A better
understanding of factors associated with death of children from ZVL may contribute to
decrease mortality.
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Introduction
Zoonotic Visceral Leishmaniasis (ZVL) is a vector-borne zoonotic disease caused by Leish-
mania infantum, which is transmitted by the bite of phlebotomine sand flies. ZVL can affect
both humans and canines, and it is considered by the WHO to be one of the most important
neglected tropical diseases, affecting about 0.5 million people per year [1]. ZVL is widespread
in South and Central America, North Africa, Southern Europe, Middle- and Far-Eastern coun-
tries, and is strongly correlated with poverty [2–3]. In the Western Mediterranean basin, sand
flies of the subgenus Larroussius, mainly Phlebotomus perniciosus, is the main vectors of ZVL
[4, 5]. In Tunisia, the zymodeme MON-1 is responsible for the majority of human and canine
cases [6–10]. The domestic dog is the main reservoir host for L. infantum [10].
ZVL is a peridomestic disease endemic mostly in rural areas, affecting families with low
social and economic status [3]. ZVL is systemic and results in the death of an infected individ-
ual if left untreated. No effective vaccine against ZVL is available for humans [11], and treat-
ment is based on chemotherapy. The only treatment of ZVL available in Tunisia is based on
meglumine antimoniate (Glucantime1) [12–13], which has been used for more than 40 years.
In addition to its toxicity to humans [14–15], resistance of L. infantum to this drug has been
confirmed [16].
Until the 1980s, cases of ZVL in Tunisia were limited to the northern humid, sub-humid
and semi-arid areas [17–20]. However, more recently ZVL has become endemic in arid areas
located in Central Tunisia following the report of several autochthonous cases [13, 21–23]. In
Tunisia, ZVL is responsible for considerable child morbidity and mortality with an estimated
incidence between 100 and 160 cases per 100,000 inhabitants [2], affecting mostly children less
than 5 years old [8, 12, 21–23]. In Tunisia, the mortality rate is 6% [12], and therefore, ZVL is
considered a major public health problem. This study aims to identify risk factors associated
with death of Tunisian children diagnosed with ZVL.
Methods
Ethical statement
The study was approved by the Ethical Review Board of the Regional Directory of Health of
the governorate of Kairouan (see supplementary materials section S1 Fig). Informed consent
was obtained from the study participants upon signing an explained agreement by their
parents (see supplementary materials: S2 Fig). Data were analyzed anonymously.
Study design and population
A retrospective study concerning a cohort of children and adolescents with up to 15 years of
age admitted for ZVL treatment between 2004 and 2014 was carried out at the paediatric
department of the University Hospital of Kairouan located in Central Tunisia, a referral center
for the treatment of ZVL. Cases were defined as patients younger than 15 years with confirmed
diagnosis of ZVL, who died during hospitalization. The survivors were considered as controls.
Diagnostic procedures
The ZVL diagnosis was performed according to the recommendations of the laboratory of the
Ministry of Health. Parasitological diagnosis was performed based on detection of amastigotes
in Giemsa stained bone marrow smears, and by isolation of promastigotes from culture media
(McNeal, Novy & Nicolle medium: NNN). Immunological tests were performed by using
immunofluorescence antibody test (IFAT) and/or polymerase chain reaction (PCR). The
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diagnosis is considered confirmed if at least one laboratory test, parasitological or immunolog-
ical test is positive.
Data collection
The medical records of all patients were reviewed and abstracted by using a standardized
data collection tool for demographic information and data related to risk factors (age, gender,
delay between onset of symptoms and admission, pallor, splenomegaly, size of splenomegaly,
hepatomegaly, nutritional status, bleeding, co-infections, leucopenia <4000 cells/mm3, hae-
moglobin <6g/dL), platelet count<50000/mm3, cytolysis and hemophagocytic syndrome).
Hypotrophy or failure to thrive is often defined as weight per age that falls below the 5th per-
centile on multiple occasions or weight deceleration that crosses two major percentile lines on
a growth chart [24]. Laboratory variables were categorized according to the following cut-off
points: (i) leucopenia (<4,000/mm3); (ii) deep anaemia (haemoglobin <6 g/dL); (iii) deep
thrombocytopenia (platelet count<50,000/mm3) and cytolysis (ALT > 80 UI/L and/or
AST> 70 UI/L).
A diagnosis of hemophagocytic syndrome was made when five or more of the following cri-
teria were fulfilled: 1) fever; 2) splenomegaly; 3) cytopenia affecting at least two of the three lin-
eages in the peripheral blood (haemoglobin < 90 g/L, platelets <100×109/L, neutrophils
<1.0×109/L); 4) hypertriglyceridemia and/or hypofibrinogenemia (fasting triglycerides3.0
mmol/L or3 SDs, fibrinogen1.5 g/L or3 SDs); 5) ferritin500 μg/L; 6) soluble CD25
(soluble IL-2 receptor)2400 U/mL; 7) low or absent NK cell activity; and/or 8) hemophago-
cytosis in the BM, spleen or lymph nodes [25].
Statistical analysis
Data analysis was performed using GNU PSPP version 0.10.4 and the R software for statistical
computing version 3.2.4 for Windows. Continuous variables were described as
means ± standard deviations. Categorical variables were summarized with absolute and rela-
tive frequencies. To compare percentages, we used Chi square test. Means were compared
using Student t-test. Potential risk factors with p-values of 0.20 or less in the initial univariate
logistic regression were included in the multivariate binary logistic regression models. The
model was reduced by means of manual backward elimination. Statistical significance was set
at p-value 0.05.
Multiple corresponding analysis (MCA) was performed using the R package FactoMiner to
detect potential multivariate association between categorical or categorized clinical variables
and the mortality by ZVL.
Results
Overall, 230 children with ZVL were included. The mean age of patients was 25.1 ± 26.2
months. Of these, 50.4% were males and 49.6% females. The mean delay between onset of
symptoms and admission was 28 ± 32.4 days. The most common symptoms were fever (94%),
splenomegaly (87.8%) and pallor (71.7%). Furthermore, hypotrophy was found in 18.3% of
children. Seven patients presented bleeding upon admission. Co-infections (viral and bacte-
rial) were documented in 51 children (22.2%). Biological tests showed profound anemia (Hb<
6g/dL), leucopenia, deep thrombocytopenia (platelet count<50,000 cells/mm3) and cytolysis
respectively in 21.7%, 59.1%, 20.4% and 71.2%. Hemophagocytic syndrome was identified in
59 patients. During this study, 14 children with ZVL died. The mortality rate was 6.1%.
Table 1 illustrates the characteristics of the study population.
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In the univariate analysis, mortality was associated with bleeding (p = 0.005), Hb< 6g/dL
(p-value = 0.021), cytolysis (p<10–3), hemophagocytic syndrome (p-value = 0.014) and treat-
ment intolerance (p-value = 0.006) (Table 2).
However, delay between onset of symptoms and admission 15 days (adjusted OR =
11.52, 95% CI [1.58–83.96], p-value = 0.016), leucopenia (adjusted OR = 9, 95% CI [1.43–
Table 1. Characteristics of children with ZVL.
Characteristic Number (n) Percentage (%)
Age (months) < 18 108122 4753
 18
Gender Male Female 116114 50.449.6
Delay between onset of symptoms and admission (days) < 15 15 14090 60.939.1
Pallor YesNo 16565 71.728.3
Splenomegaly YesNo 20228 87.822.4
Size of splenomegaly < 2 2 65165 28.371.7
Hepatomegaly YesNo 102128 44.355.7
Nutritional status Eutrophic Hypotrophic 18842 81.718.3
Bleeding YesNo 7223 397
Co-infections Yes No 51179 22.277.8
Leucopenia Yes No 13694 59.140.9
Haemoglobin (g/dL) < 6 6 50180 21.777.3
Platelet count (/mm3) <50,000 50,000 47183 20.479.6
Cytolysis YesNoNot done 1862222 71.29.69.6
Hemophagocytic syndrome YesNo 59171 25.774.3
Death YesNo 14216 6.193.9
https://doi.org/10.1371/journal.pone.0189725.t001
Table 2. Univariate analysis of risk factors of mortality in children with ZVL.
Factor Died (%) (n = 14) Survivors (%) (n = 216) OR [95%CI] p
Age 8 (7.4) 6 (4.9) 100 (92.6) 116 (95.1) 1.55 [0.52–4.6] 0.43
< 18 months 18 months
Gender 8 (6.9) 6 (5.3) 108 (93.1) 108 (94.7) 1.33 [0.45–3.97] 0.6
Male Female
Delay between onset of symptoms and admission 15 days 8 (8.9) 6 (4.3) 82 (91.1) 134 (65.7) 2.18 [0.73–6.5] 0.08
< 15 days
Pallor YesNo 2 (3.1) 12 (7.3) 63 (96.9) 153 (92.7) 0.4 [0.08–1.86] 0.37
Splenomegaly YesNo 13 (6.4) 1 (3.6) 189 (93.6) 27 (96.4) 1.86 [0.23–14.8] 0.55
Size of splenomegaly 2 fingers< 2 fingers 8 (4.8) 6 (9.2) 157 (95.2) 59 (90.8) 0.5 [0.16–1.5] 0.34
HepatomegalyYesNo 5 (4.9) 9 (7) 97 (95.1) 119 (93) 0.68 [0.22–2.1] 0.5
Nutritional statusHypotrophicEutrophic 1 (2.4) 13 (6.9) 41 (97.6) 175 (93.1) 0.33 [0.02–2.52] 0.47
Bleeding YesNo 3 (42.9) 11 (4.9) 4 (57.1) 212 (95.1) 14.5 [2.87–72.7] 0.005
Co-infections YesNo 2 (3.9) 12 (6.7) 49 (96.1) 167 (93.3) 0.57 [0.12–2.62] 0.74
Leucopenia Yes No 8 (8.6) 6 (4.4) 85 (91.4) 130 (95.6) 2.04 [0.68–6.08] 0.19
Haemoglobin (g/dL) < 6 6 7 (14) 7 (3.9) 43 (86) 173 (96.1) 4 [1.33–12] 0.022
Platelets counts (/mm3) < 50,000 50,000 7 (14.9) 7 (3.8) 40 (85.1) 176 (96.2) 4.37 [1.45–13.2] 0.011
Cytolysis Yes No 6 (27.3) 5 (2.7) 16 (72.7) 181 (81) 13.6 [3.73–49.5] <10−3
Hemophagocytic syndrome YesNo 8 (13.6) 6 (3.5) 51 (86.4) 165 (96.5) 4.31 [1.43–13] 0.014
OR: Odds Ratio; CI: Confidential Interval
https://doi.org/10.1371/journal.pone.0189725.t002
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56.63], p-value = 0.019), bleeding (adjusted OR = 24.38, 95% CI [1.85–321.75], p-
value = 0.015) and cytolysis (adjusted OR = 28.13, 95% CI [4.55–173.6], p-value <10–3), were
identified by multivariate logistic regression as independent risk factors for mortality in chil-
dren with ZVL (Table 3).
On the other hand the MCA did not show a clear correspondence between the categorized
clinical variables and the mortality from ZVL (Fig 1). However, for the same data other associ-
ation between the clinical variables themselves can be seen. For example, an association
between splenomegaly, hepatomegaly and platelet count< 50,000. The distribution of the
cases (mortality) seems not to be associated to a single clinical variable.
Discussion
Mortality from ZVL in the pediatric environment remains significant and varies according to
countries and health care system access throughout the world from 3.3 to 10% [26–28]. Few
Table 3. Multivariate analysis of risk factors of mortality in children with ZVL.
Factor Adjusted OR 95%CI p
Delay between onset of symptoms and admission 15 days 11.52 [1.58–83.96] 0.016
Leucopenia 9 [1.43–56.63] 0.019
Bleeding 24.38 [1.85–321.75] 0.015
Cytolysis 28.13 [4.55–173.6] <10−3
OR: Odds Ratio; CI: Confidential Interval
https://doi.org/10.1371/journal.pone.0189725.t003
Fig 1. Representation of the categorized clinical data and variables versus morbidity in 2 dimensions resulting from the MCA, in order to
describe potential grouping either for individual observations or variables.
https://doi.org/10.1371/journal.pone.0189725.g001
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studies have examined the factors denoting a poor prognosis of ZVL in children [26, 27, 29,
30]. In our study, delay between onset of symptoms and admission 15 days, bleeding, leuco-
penia and cytolysis were considered as independent risk factors of mortality in Tunisian chil-
dren with ZVL.
Prognostic factors for ZVL in the child population were previously assessed in north Tuni-
sia [29]. In this study, visit delayed more than 56 days, fever lasting more than 21 days, normal
or low temperature, haemorrhagic syndrome, haemoglobin rate< 5.5 g/dL, sedimentation
rate>25 mm and hypoalbuminemia <30 g/L were identified as poor prognostic factors. In
accordance with this study, we found that only the delay between onset of symptoms and
admission 15 days and especially bleeding were identified by logistic regression as signifi-
cant independent risk factors for mortality in children with ZVL.
Despite the fact that 74% of our study population was under 15 months, we did not find
that age carried a worse prognosis, as reported in a previous Tunisian study [29]. Increased
risk of poor evolution was reported in children younger than 6 months [31], 12 months [27,
32], 18 months [30], 5 years [33] and even 6 years [34]. The difference between these studies
could be explained by the diversity of samples size and particularly the number of patients
recruited and the age distribution.
Several studies performed in Latin American and in Africa reported that clinical symptoms
at admission such as jaundice, splenomegaly, haemorrhagic syndrome, malnutrition and
dyspnoea are considered as factors related to death or severity of ZVL [26, 27, 30, 33, 35, 36].
Scoring system suggests that these clinical manifestations could predict ZVL mortality and
contribute to better clinical management [31]. However, our results showed that only bleeding
is strongly associated with mortality. The detection of bleeding upon admission or during the
course of treatment is crucial in the identification of severity [29, 33]. Haemorrhage was
described as the consequence of a ZVL induced inflammatory process with a cascade of events
comprising activation of the inflammatory response, development of endothelial lesions, acti-
vation of intravascular clotting, hypoperfusion, hypoxaemia and cell death [37].
As reported in some Brazilian studies [26, 30], our results showed that severe anaemia (hae-
moglobin <6 g/dL) is not associated with increased mortality. However, this finding is not in
accordance with studies performed in Tunisia [29], and in Sudan [36, 38].
Despite the fact that platelet counts less than 50,000 cells/ mm3 and even less than 85,000
cells/ mm3 have been described as poor prognostic factors in Brazilian children with ZVL
[26,30], the Leishmaniasis Surveillance Program of the Brazilian Ministry of Health recom-
mended hospitalization for patients with platelet counts <50,000 /mm3. However, we found
no association between platelet counts <50,000 /mm3 (which was observed in 20.4% of
patients) in multivariate model and fatality. It was concluded that rather than attempting to
define a standard limit of thrombocytopenia, it is more important to assess each case separately
in order to decide about the most appropriate hemotherapeutic approach [33].
While neutropenia constituted a predictor for ZVL severity [26, 31, 33], patients with these
conditions were probably more susceptible to bacterial infections [33]. Our results showed
that a white cell count less than 4,000/mm3 is a poor prognostic factor for Tunisian children
suffering from ZVL, and therefore, antibiotherapy is highly recommended. While AST and
ALT constituted prognosis factors of intermediary evidence in the prediction of poor progno-
sis [33], we found out that these variables were strongly associated with death of Tunisian chil-
dren. Increased levels of liver enzymes in patients at admission may signal the presence of
hepatitis caused by Leishmania infection [39]. Associated bacterial co-infection increases the
risk of death from ZVL both in children and adults [26, 33, 35,40]. Only 22.2% of our patients
suffered from bacterial co-infection but without influencing their prognosis. It is important to
point out the several clinical and biological data are missing. As a mono-center study with a
Zoonotic visceral leishmaniasis and children mortality
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limited sample size, several parameters that can directly influence mortality have not been
evaluated including kidney function, liver function and drug toxicity.
In conclusion, our study confirmed the association between death and bleeding and delay
of diagnosis in Tunisian children with ZVL. Furthermore, cytolysis and leucopenia must be
considered in the management of this pathology.
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